IP Library Granted Patent US 9,161,598
Granted Patent B2
US 9,161,598 · App. 14/109,977 · Granted Oct 20, 2015

Ophthalmic devices for delivery of beneficial agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,161,598
App. No.
14/109,977
Granted
Oct 20, 2015
Kind
B2
Abstract

Contact lenses comprising phosphorylcholine groups release beneficial polyionic or guanidinium-containing agents.

Claims (16)

1. An unworn contact lens immersed in a packaging solution and sealed in a package, said contact lens comprising:

(a) a hydrogel comprising integral phosphorylcholine groups; and

(b) a releasable ionic agent electrostatically bound to the phosphorylcholine groups, wherein the ionic agent is polyionic or comprises at least one guanidinium group or is both polyionic and comprises at least one guanidinium group.

2. The contact lens of claim 1 , wherein the hydrogel comprises a hydrated polymerization product of a monomer mixture comprising 2-methacryloyloxyethyl phosphorylcholine (MPC).

3. The contact lens of claim 2 , wherein the monomer mixture comprises about 10 wt. % to 20 wt. % MPC.

4. The contact lens of claim 1 , wherein the ionic agent is epinastine.

5. The contact lens of claim 1 , wherein the ionic agent is polyionic.

6. The contact lens of claim 1 , wherein the ionic agent comprises at least one guanidinium group.

7. The contact lens of claim 1 , wherein the ionic agent comprises at least two guanidinium groups.

8. The contact lens of claim 1 , wherein the ionic agent is polyhexamethylene biguanide.

9. The contact lens of claim 1 , wherein the ionic agent comprises at least two arginine groups.

10. The contact lens of claim 1 , wherein the ionic agent is polyarginine.

11. The contact lens of claim 1 , wherein the ionic agent is epsilon polylysine.

12. The contact lens of claim 1 , wherein the ionic agent comprises at least two sulfonate groups.

13. The contact lens of claim 1 , wherein the ionic agent is polystyrene sulfonate.

14. The contact lens of claim 1 , wherein the agent is 1-Dodecanaminium N,N-dimethyl-N-(3-((2-methyl-1-oxo-2-propenyl)amino)propyl)-chloride, polymer with N-(3-(dimethylamino)propyl)-2-methyl-2-propenamide and 1-ethenyl-2-pyrrolidone (polyquaternium-55).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2020
From: COOPERVISION INTERNATIONAL HOLDING COMPANY, LP
To: COOPERVISION INTERNATIONAL LIMITED
Reel/Frame 054370/0631 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2014
From: ROGERS, VICTORIA; LUK, ANDREW; BACK, ARTHUR; ZALIPSKY, SAMUEL
To: COOPERVISION, INC.
Reel/Frame 032865/0243 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2014
From: COOPERVISION, INC.
To: COOPERVISION INTERNATIONAL HOLDING COMPANY, LP
Reel/Frame 032865/0257 →